Dr. Joel M Apides

MD | Neurology


  34800 Bob Wilson Dr, Nmcsd Neurosciences Suite 201, San Diego
     California, 92134-1098
  619-532-7275    Maps & Directions
Dr. Joel M Apides is a San Diego, California based neurologist who is specialized in Neurology. His current practice location is 34800 Bob Wilson Dr, Nmcsd Neurosciences Suite 201, San Diego. Patients can reach him at 619-532-7275. Dr. Joel M Apides is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1659344158.
Dr. Joel M Apides specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Joel M Apides speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Joel M Apides
Specialization: Neurology
Gender:Male
Credentials: MD
Practice Address:34800 Bob Wilson Dr, Nmcsd Neurosciences Suite 201, San Diego,
California, 92134-1098
Phone:619-532-7275
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1659344158
NPI Enumeration Date: 07 Feb, 2006
NPI Last Update On: 16 May, 2011

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Joel M Apides
Bob Wilson Drive, Nmcsd Neurology34800
San Diego, California
Zip: 92134
Phone Number: 619-253-6722
Patients can reach Dr. Joel M Apides at 34800 Bob Wilson Dr, Nmcsd Neurosciences Suite 201, San Diego, California or can call to book an appointment on 619-532-7275.
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.